WANBURY
Back to Income Statement
|
WANBURY Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹9.32 | ₹17.09 | ₹-3.18 | ₹24.94 | ₹-5.04 |
What is the latest Earnings Per Share (EPS) of WANBURY ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹9.32 |
| Mar2024 | ₹17.09 |
| Mar2023 | ₹-3.18 |
| Mar2022 | ₹24.94 |
| Mar2021 | ₹-5.04 |
How is Earnings Per Share (EPS) of WANBURY Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.32 | -45.47 | |
| Mar2024 | ₹17.09 | Positive | |
| Mar2023 | ₹-3.18 | Negative | |
| Mar2022 | ₹24.94 | Positive | |
| Mar2021 | ₹-5.04 | - | |
Compare Earnings Per Share (EPS) of peers of WANBURY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WANBURY | ₹696.2 Cr | -11.7% | -22% | -13.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
WANBURY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WANBURY | -11.7% |
-22% |
-13.4% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses